Teijin stock
Price history
+41.43% over the period1 year: from ¥1,268.50 (November 17, 2025) to ¥1,794.00 (November 16, 2026), +41.43%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | ¥1,794.00 |
| October 30, 2026 | ¥1,607.00 |
| September 30, 2026 | ¥1,690.00 |
| August 31, 2026 | ¥1,758.00 |
| July 31, 2026 | ¥1,637.00 |
| June 30, 2026 | ¥1,626.00 |
| May 29, 2026 | ¥1,651.50 |
| April 30, 2026 | ¥1,574.50 |
| March 31, 2026 | ¥1,632.00 |
| February 27, 2026 | ¥1,733.50 |
| January 30, 2026 | ¥1,494.50 |
| December 30, 2025 | ¥1,355.50 |
| November 28, 2025 | ¥1,313.50 |
| November 17, 2025 | ¥1,268.50 |
At a glance
The company
Produce fibers, films, composites, healthcare products and medical devices, and IT solutions for industrial and medical markets
Latest results
Quarter to September 30, 2026 · EPS ¥38.45
Next event
Dividend
TickerLandia's take on Teijin
- Pricier than similar companies: trailing 12-month P/E 18 vs 11 (+64%) in a group of 11.
- Strong point: Dividend (80/100 in its group). Weak point: Growth (11/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−4.47% from the 52-week high
Analysts · 5 analysts
Average target¥1,582.00−11.82% vs. price
Buy 0 · Hold 4 · Sell 1 · Hold
TickerLandia Fingerprint: Teijin
Compared with similar companies: very low growth, very low earnings stability, and very high dividend.
Financials and price compared with 56 companies in the conglomerates industry, worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.
Pricelow24
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 18.0 63 Forward P/E 5.03 17 Price/book 0.83 23 Price/sales 0.40 15 EV/EBITDA 2.69 1 Profitabilityaverage51
How much it earns on revenue and capital.
Metric Value Position in group ROE 4.8% 15 Gross margin 31.4% 60 Net margin 2.2% 12 ROA 9.1% 92 Operating margin 16.0% 74 Earnings stabilityvery low15
How steady its margins were over the last five annual reports.
Metric Value Position in group Loss-making yearscounts in reverse: lower means more earnings stability 2 of 5 annual reports 8 Margin variabilitycounts in reverse: lower means more earnings stability 5.9% 22 Growthvery low11
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +4.70% 17 Earnings growth (year over year) −113.73% 5 Average revenue growth (3 years) −5.01% 10 Financial strengthlow36
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 1.93 71 Debt/equitycounts in reverse: lower means more financial strength 0.69 37 Interest coverage −10.1 1 Dividendvery high80
How much it returns to shareholders, and for how long.
Metric Value Position in group Payout ratiopays out more than its earnings 115.4% 97 Dividend yield 2.8% 68 Consecutive dividend years 27 years 76 Market momentumstrong74
How the stock has moved compared with the market.
Metric Value Position in group Distance from 200-day average +9.53% 78 1-year return +40.91% 82 Relative strength (3 months) +13.44% 75 Relative strength (6 months) +8.20% 63 Risklow33
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 12.8% 3 Volatility (60 days) 45.3% 65 Beta (1 year) 0.45 31
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Teijin is pricier than similar companies
Teijin's P/E (trailing 12 months): 18.0, +64% against the median of a group of 11 similar companies (11.0).
Compared with 11 similar companies
| Metric | Teijin | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 18.0 | High | |
| Forward P/E | 5.03 | Middle | |
| Operating margin | 16.0% | High | |
| ROE | 4.8% | Low | |
| Debt/equity | 0.69 | Middle |
Grey band: the middle half of the group; tick: the median; dot: Teijin. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
¥217.62B
Latest quarter · Q3 2026
Net income
¥7.44B
Latest quarter · Q3 2026
Quarterly net margin
3.4%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- ¥348.78B
- P/E
- 18.0
- EPS
- -¥456.33
- Volume
- 502.5K
- Daily trading
- €9.01M
- Dividend yield
- 2.79%
How Teijin is changing
All resultsRevenue grew 0.9% a year on average over the last 5 years
Operating margin fell from 1.3% to −7.9%
Profitable in 3 of 5 fiscal years
Returns
Teijin returns with dividends
¥1,000 invested in Teijin 5 years ago, on November 16, 2021, would be worth ¥1,464 today with dividends reinvested: +46.39% in total, +7.92% per year. On price alone it would be ¥1,255 (+25.54%).
| Period | Teijin | Nikkei 225 | ¥1,000 becomes |
|---|---|---|---|
| 1 month | +6.47% | −6.39% | ¥1,065 |
| 6 months | +6.69% | −0.42% | ¥1,067 |
| Year to date | +32.35% | +21.48% | ¥1,323 |
| 1 year | +45.83% | +21.52% | ¥1,458 |
| 3 years | +47.05% | +82.95% | ¥1,471 |
| 5 years | +46.39% | +105.15% | ¥1,464 |
| 10 years | +20.68% | +242.35% | ¥1,207 |
Over the last 6 months it has done better than 72% of the stocks in the Industrials sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. Nikkei 225: price only. Calculate your investment
The chart in detail
Teijin: technical analysis
Teijin is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 63.4% below its all-time closing high (¥4,895.00, January 10, 1990).
- Trend
- Upward
- RSI (14 sessions)
- 59
- Between 30 and 70
- vs 200-session average
- +8.65%
Support and resistance
Price areas where Teijin has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance¥1,824.50+1.70%2 touches, last on September 1, 2026
- Last price¥1,794.00
- Support¥1,757.75−2.02%6 touches, last on September 18, 2026
- Support¥1,700.50−5.21%5 touches, last on October 16, 2026
- Support¥1,621.60−9.61%5 touches, last on October 5, 2026
Volatility and risk
Over the last year it has moved less than the Nikkei 225.
- Beta (1 year) vs Nikkei 225
- 0.46
- Volatility (60 sessions, annualised)
- 45.3%
- Largest fall in the last year
- −12.83%
Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Teijin: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Teijin has been April: +2.33% on average, positive in 21 years out of 37. The weakest has been August: −1.82% on average, positive in 15 years out of 37. November, the current month, has been positive in 17 years out of 36 (−0.69% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.13% | −0.37% | 17 of 36 |
| February | −0.54% | −0.53% | 15 of 37 |
| March | +1.51% | +1.40% | 22 of 37 |
| April | +2.33% | +1.83% | 21 of 37 |
| May | −0.55% | −0.78% | 17 of 37 |
| June | +0.50% | 0.00% | 18 of 37 |
| July | −1.37% | −2.27% | 15 of 37 |
| August | −1.82% | −1.55% | 15 of 37 |
| September | −1.06% | −0.63% | 16 of 37 |
| October | +0.94% | +1.46% | 20 of 37 |
| November | −0.69% | 0.00% | 17 of 36 |
| December | +0.83% | −0.01% | 18 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Teijin and its competitors
Based in Tokyo, Teijin Limited has existed since its incorporation in 1918. The group works across fibers, films and sheets, composites, healthcare and IT, selling in Japan and abroad. Its range includes aramid fibers, carbon and glass fiber composites for automotive use, polycarbonate and polyester materials, and resins. In healthcare it offers pharmaceuticals for bone and joint, respiratory and cardiovascular diseases, home oxygen therapy and non-invasive ventilation devices, as well as implantable medical devices and regenerative medical products.
- Headquarters
- Tokyo, Japan
- Employees
- 15,689
- Founded
- 1918
- Chief executive
- Akimoto Uchikawa
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Teijin3401 | $2.18B | 16.0% | 18.0 | +6.69% |
| Nrw HoldingsNWH | $2.1B | 5.7% | 20.3 | −12.34% |
| Keio9008 | $2.88B | 10.2% | 11.0 | +2.82% |
| DeNA2432 | $1.5B | 11.7% | 7.51 | −2.98% |
| Mitsui Kinzoku5706 | $5.51B | 10.4% | 7.72 | −69.78% |
| Kingboard Holdings0148 | $5.59B | 14.6% | 9.63 | −31.30% |
Same industry or related industries, similar size. Compare Teijin with its competitors · Full profile
